Denali Therapeutics investor relations material
Listen to the latest call from Denali Therapeutics
Denali Therapeutics, Inc. is a biopharmaceutical company that discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company has been operating its business since 2013.
Ticker
DNLICountry
US
Upcoming events
Dig deeper into the Denali Therapeutics fundamentals on Quartr.
